Telescope Innovations Corp. (CSE:TELI)

Market Cap	28.13M
Revenue (ttm)	5.78M
Net Income (ttm)	-1.56M
Shares Out	85.25M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,394
Average Volume	60,912
Open	0.3400
Previous Close	0.3400
Day's Range	0.3150 - 0.3400
52-Week Range	0.2300 - 0.6500
Beta	1.57
RSI	45.11
Earnings Date	Dec 22, 2025

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. The company has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. is based in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Henry Dubina
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TELI

Financial Performance

In 2025, Telescope Innovations's revenue was 5.78 million, an increase of 30.53% compared to the previous year's 4.43 million. Losses were -1.56 million, 18.1% more than in 2024.